Vancouver, BC, September 1, 2020--Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, announced that Karn Manhas, Founder and CEO of Terramera and agtech industry pioneer, has joined Qu Biologics' Board of Directors.
|